ロード中...
Prognostic Value of Germline DNA Repair Gene Mutations in De Novo Metastatic and Castration‐Sensitive Prostate Cancer
BACKGROUND: Germline DNA damage repair gene mutations (gDDRm) have been found in approximately 12% of patients with metastatic prostate cancer (mPCa). Previous studies of the clinical impact of gDDRm have mainly been in the setting of metastatic castration‐resistant prostate cancer (mCRPC). This stu...
保存先:
| 出版年: | Oncologist |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7356812/ https://ncbi.nlm.nih.gov/pubmed/32190957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0495 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|